Cited by 653Gene expression and cancer classificationBreast Cancer Treatment StudiesCancer-related Molecular Pathways

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Common markers of proliferation

Whitfield, Michael L., George, Lacy K., Grant, Gavin D., Perou, Charles M.·2006·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

When normal tissue and tumour samples are compared by microarray analysis, the biggest differences most often occur in the expression levels of genes that control cell proliferation. However, this difference is detected whenever mRNA samples that are taken from two cell populations with different proliferation rates are compared. Although the exact genes that comprise this 'proliferation signature' often differ, they are almost always genes that are involved in the fundamental process of cell proliferation. Can the proliferation signature be used to improve our understanding of the cell cycle and cancer pathogenesis, as well as being used as a biomarker for cancer diagnosis and prognosis?

Integrity signals

Registry

Crossref · 10.1038/nrc1802

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Self-citation
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Self-citation
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
Self-citation
Comprehensive Identification of Cell Cycle–regulated Genes of the YeastSaccharomyces cerevisiaeby Microarray Hybridization
Spellman, P. T., Sherlock, G. J., Zhang, M. Q., Iyer, V. R., Anders, K. R., Eisen, M. B., Brown, P. O., Botstein, D., & Futcher, B. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3273 · Cited by 4,724
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
Rosenwald, A., Wright, G. W., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Müller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,832

Show all 66 references

Research works printed but not linked: 2

Stewart, C. F. & Ratain, M. J. in Cancer: Principles and Practice in Oncology (eds. DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 452–467 (Lippincott–Raven, Philadelphia, 1997).
O'Dwyer, P. J., Johnson, S. W. & Hamilton, T. C. in Cancer Principles and Practices of Oncology (eds. DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 418–432 (Lippincott–Raven, Philadelphia, 1997).

Sorted by citations

Items 501–600 of 653

Ki-67, CD105, and α-smooth muscle actin expression in oral squamous cell carcinoma corresponds with different forms of tobacco consumption habits
Gadbail, A. R., Sarode, S. C., Chaudhary, M. S., Gondivkar, S. M., Tekade, S. A., Yuwanati, M. B., Sarode, G. S., Hande, A. H., & Patil, S. V. (2022) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1307_20 · Cited by 2
Gene Expression Microarrays in Cancer Research
Yan, J., & Gu, W. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6_20 · Cited by 2
“However, the exact gene identities that comprise these signatures often vary greatly [ 66 ].”
Background
Organic Synthesis in Drug Discovery and Development
Šunjić, V., & Parnham, M. J. (2011) · Springer eBooks · doi:10.1007/978-3-0348-0125-6_1 · Cited by 2
The evolution of targeted biologic therapies
Sledge, G. W. (2007) · The Breast · doi:10.1016/j.breast.2007.07.002 · Cited by 2
Predicting the impact of sequence motifs on gene regulation using single-cell dataPreprint
Hepkema, J., Lee, N. K., Stewart, B. J., Ruangroengkulrith, S., Charoensawan, V., Clatworthy, M. R., & Hemberg, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.26.400218 · Cited by 2
TCF7L2 is a master regulator of muscle wasting in severe cancer cachexiaPreprint
Leong, M. L., Karjalainen, K., & Ruedl, C. (2022) · Research Square · doi:10.21203/rs.3.rs-2033935/v1 · Cited by 2
Pan-cancer evolution signatures link clonal expansion to dynamic changes in the tumour immune microenvironmentPreprint
Yang, X., Liu, W., Macintyre, G., Loo, P. V., Markowetz, F. M., Bailey, P. J., & Yuan, K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.12.560630 · Cited by 2
“Proliferation and wound healing signatures were related to the cell cycle phase and associated with poor prognosis in cancer patients 45,46 .”
Background
Establishing a glycolysis-linked multigene prognostic signature in lung adenocarcinoma: a multicenter integrative approach
Dong, W., Jing, S., & Mu, X. (2025) · Journal of Thoracic Disease · doi:10.21037/jtd-2025-1438 · Cited by 1
Necroptotic signaling orchestrates glioblastoma malignancy and potentiates temozolomide response
Li, Y., Qiu, Y., Gao, W., Geng, L., Wu, Z., Zhang, T., Pan, J., Lu, J., Zhang, D., Idris, A., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08377-3 · Cited by 1
“Consistently, ﬂ ow cytometric analyses of U251 and A172 GBM lines revealed that loss of RIPK1 promoted S-and G2/M-phase arrest (Fig.”
Pan-cancer evolution signatures link clonal expansion to dynamic changes in the tumor immune microenvironment
Yang, X., Liu, W., Macintyre, G., Loo, P. V., Markowetz, F. M., Bailey, P. J., & Yuan, K. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117098 · Cited by 1
Molecular phenotypes stratify small cell lung cancer for targeted therapy and immunotherapy
Zhang, J., Liu, Y., Yuan, H., Zhan, N., Deng, J., Tang, L., Li, X., Liu, Y., Zhao, W., Liu, S., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03390-5 · Cited by 1
“The “ FindAllMarkers ” function was employed to identify markers for each identi ﬁ ed cluster.”
Mesenchymal-epithelial transition supports rapid repair of the endometrial epithelium during postpartum uterine regeneration
Wang, Z., de Almeida, J. M., Davenport, K. M., Behura, S. K., & Patterson, A. L. (2026) · Communications Biology · doi:10.1038/s42003-026-10236-6 · Cited by 1
IL-15 and IL-21 synergy improves anti-tumor efficacy of iPSC-derived cytotoxic T cells in solid tumors
Ishikawa, A., Waseda, M., Ishii, T., Kawai, Y., & Kaneko, S. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.036 · Cited by 1
Whole-protein screening and multi-modal profiling of antigen-specific CD4+ T cells at single-cell resolution
Zhang, R., Qi, J., McKasson, M., Choi, J., Gutierrez, V., Brennan, C., Hong, S., Chour, W., Ng, R. H., Xie, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72396-7 · Cited by 1
“Additionally, a small cluster of cells displays high expression of proliferation markers, including MKI67, MYBL2, BUB1, PLK1, and CCNE1 53 .”
Mini-Chromosome Maintenance Protein Family: Novel Proliferative Markers - The Pathophysiologic Role and Clinical Application
Karimi, S., & Sadr, M. (2011) · InTech eBooks · doi:10.5772/18162 · Cited by 1
Computing a Predictor Set Influence Zone through a Multi-Layer Genetic Network to Explore the Role of Estrogen in Breast Cancer
Lima, L. D. A., Ris, M., Barrera, J., Brentani, M. M., & Brentani, H. (2012) · Advances in Breast Cancer Research · doi:10.4236/abcr.2012.13004 · Cited by 1
“Genes addressed to biological func- tions associated to cell proliferation are related to cancer [24] and estrogen can up-regulate or down-regulate those genes [19].”
Background
Prediction of Radiation Response
Begg, A. C. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5897-7.00005-6 · Cited by 1
Pathology of Neuroendocrine Neoplasms: Morphological, Immunophenotypical, and Circulating Molecular Markers
Rosa, S. L., Bongiovanni, M., & Uccella, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-62506-5_2 · Cited by 1
Identification of Pathway-Based Biomarkers with Crosstalk Analysis for Overall Survival Risk Prediction in Breast Cancer
Liu, X., Su, L., Li, J., & Ou, G. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.689715 · Cited by 1
MicroRNA-532-3p Modulates Colorectal Cancer Cell Proliferation and Invasion via Suppression of FOXM1
Mahajan, K., Das, A. V., Alahari, S. K., Pothuraju, R., & Nair, S. A. (2024) · Cancers · doi:10.3390/cancers16173061 · Cited by 2
“This has made FOXM1 a crucial factor in the occurrence and progression of cancer as a group of diseases that arises from dysregulation in a cell cycle [46,47].”
Background
Estudio de las características de diferentes cánceres primitivos basado en las metástasis óseas
Aubach, L. L. R., Guillén, L. M., Palau, N. M., Seijas, M. C., Torres-Palou, R., & Pallisó, F. (2008) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(08)72488-7 · Cited by 1
Progenitor Cells and Cardiac Homeostasis
Leri, A., Hosoda, T., Rota, M., Bearzi, C., Urbanek, K., Bolli, R., Kajstura, J., & Anversa, P. (2007) · Elsevier eBooks · doi:10.1016/b978-012370615-7/50041-x · Cited by 1
Over-expression of chromatin assembly factor 1 subunit A (CHAF1A) facilitates cell proliferation in non-small cell lung cancer (NSCLC)
Zhao, H., Duan, Y., Liu, T., Li, L., Li, W., & Li, J. (2019) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2019.1627245 · Cited by 1
“An important mechanism for malignant tumour pathogenesis and development is the out-of-control and rapid cell proliferation [14].”
Background
A CROSS SECTIONAL STUDY OF BREAST CANCER HISTOMORPHOLOGY AND ITS CORRELATION WITH ER/PR, HER 2NEU AND KI-67 EXPRESSION IN A TERTIARY CARE HOSPITAL AT KANPUR
Singh, M., Dwivedi, S., Mishra, Y., & Tripathi, S. (2021) · Indian Journal Of Applied Research · doi:10.36106/ijar/9500487 · Cited by 1
Cancer Transcriptome Sequencing and Analysis
Morin, R. D., & Montgomery, S. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396967-5.00003-7 · Cited by 1
Molecular and prognostic markers in prostate cancer
HALVORSEN, O. J. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.0s123.x · Cited by 1
Synergism of IL10R and TLR9 signaling affects gene expression, proliferation and metabolism in B cells: A comparative study of STAT3/NF-kB and c-Myc mediated effects
Feist, M. (2016) · doi:10.53846/goediss-5867 · Cited by 1
Efeitos da 5-iodotubercidina em linhagens de melanoma humano parentais e resistentes ao inibidor de BRAF
Santos, S. (2019) · doi:10.11606/d.9.2019.tde-18032019-150858 · Cited by 1
Whole exome precision oncology targeting synthetic lethal vulnerabilities across the tumor transcriptomePreprint
Lee, J. S., Nair, N. U., Chapman, L. M., Sinha, S., Wang, K., Cha, H., Rubin, E., Berger, R., Lazar, V., Kurzrock, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.16.951699 · Cited by 1
Reconstitution of Prospermatogonial Specification In vitro from Human Induced Pluripotent Stem CellsPreprint
Hwang, Y., Suzuki, S., Seita, Y., Ito, J., Handa, Y., Aso, H., Sato, K., Hermann, B. P., & Sasaki, K. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3611046 · Cited by 1
ETV2 upregulation marks the specification of early cardiomyocytes and endothelial cells during co-differentiationPreprint
Cao, X., Mircea, M., Yakala, G. K., van den Hil, F. E., Brescia, M., Mei, H., Mummery, C. L., Semrau, S., & Orlova, V. V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.15.516686 · Cited by 1
Tissue microenvironment dictates the state of human induced pluripotent stem cell-derived endothelial cells of distinct developmental origin in 3D cardiac microtissuesPreprint
Cao, X., Mircea, M., van den Hil, F. E., Mei, H., Neumann, K., Anastassiadis, K., Mummery, C. L., Semrau, S., & Orlova, V. V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.22.517426 · Cited by 1
Detecting phenotype-specific tumor microenvironment by merging bulk and single cell expression data to spatial transcriptomicsPreprint
Zhu, W., Tang, H. D., & Zeng, T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.23.581547 · Cited by 1
“…heterogeneity in the spatial dimen-sion, we next explored the functional heterogeneity in tumor microenvironment by several signature scores (in Figure 4E and Supplementary Figure 3C), particularly the association with cellular proliferation ([40]) and Epithelial-Mesenchymal Transition (EMT).”
Background
A Landscape of Genetic and Cellular Hallmarks in Chronic Kidney DiseasePreprint
Luo, Y., Lin, L., de Araujo, I. B. B. A., Kristensen, A. M., Haskó, J., Madsen, M., Keller, A. K., Olsen, A. L., Zhao, X., Fang, W., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4681754/v1 · Cited by 1
Decoding Breast Cancer Heterogeneity via Multi-Omics Integration and Language Model-Based InterpretationPreprint
Yasrab, R., Agrawal, R., Saber-Ayad, M. M., & El-Hadidi, M. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.26.661832 · Cited by 1
Differential expression of genes influencing mitotic processes in cord blood mononuclear cells after a pre-conceptional micronutrient-based randomized controlled trial: Pune Rural Intervention in Young Adolescents (PRIYA)Preprint
Khare, S., Madhok, A., Patta, I., Sukla, K. K., Wagh, V. V., Kunte, P. S., Raut, D., Bhat, D., Kumaran, K., Fall, C. H., et al. (2021) · medRxiv · doi:10.1101/2021.08.25.21262585 · Cited by 1
Omitting tumor proliferation from prognostic gene expression models: a preregistered cross-cancer test, a transcriptome-wide measurement, and a survey of how often the omission is madePreprint
Nam, S. W. (2026) · Research Square · doi:10.21203/rs.3.rs-11273325/v1 · Cited by 1
Classification moléculaire des cancers du sein. Implications pratiques
Penault-Llorca, F. M. (2008) · Springer eBooks · doi:10.1007/978-2-287-71478-8_26
Microarray-based expression signatures: potential application for individualized cancer treatment
Starmans, M. H. W. (2011) · doi:10.26481/dis.20111125ms
Geração e caracterização de linhagens isogênicas portadoras de mutantes de p53: modelo para avaliar a estratégia de reparação dos genes p53 e p16 INK4A na presença dos mutantes p53R175H e p53R248Q.
Souza, F. D. C. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2012.tde-26072012-102241
Regulation of cyclin E stability in Xenopus laevis embryos
Brandt, Y. I. (2010) · UNM’s Digital Repository (University of New Mexico)
Translational Control of Cell Proliferation and Viability in Normal and Neoplastic Cells
Avdulov, S. V., Gómez-García, J. R., Bitterman, P. B., & Polunovsky, V. A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_18
Emergence of nanomedical devices for the diagnosis and treatment of cancer: the journey from basic science to commercialisation
Curreli, M., Nadershahi, A. H., & Shahi, G. (2008) · International Journal of Technology Transfer and Commercialisation · doi:10.1504/ijttc.2008.021029
“Today, a cancer’s growth is typically monitored by measuring the concentration of biomarkers, which are, for example, specific proteins found in abnormal levels when a tumour is growing (Whitfield et al., 2006) and by imaging techniques that show the progress of cancer (Daly and Cohen, 1989; Tempany and McNeil, 2001).”
Background
Études génomiques à haut débit et classification des tumeurs de la corticosurrénale
Assié, G. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.016
Mouse Models for Gastrointestinal Cancer
Goodlad, R. A. (2007) · The Cancer Handbook · doi:10.1002/9780470025079.chap384
Marcadores tumorales en cáncer de cabeza y cuello y su utilidad clínica
Vilaplana, P. G. (2007) · Medicina Clínica · doi:10.1157/13113775
Representação de sistemas biológicos a partir de sistemas dinâmicos: controle da transcrição a partir do estrógeno.
Ris, M. (2008) · doi:10.11606/t.95.2008.tde-27052008-170955
Role of WIP in metastasis and study of transcriptional regulation of N-Wasp
Amrita, S. S. (2016) · doi:10.32657/10356/67318
- Nanowire Transistor–Based DNA Methylation Detection
(2012) · CRC Press eBooks · doi:10.1201/b12138-44
Structural Learning of Genetic Regulatory Networks Based on Prior Biological Knowledge and Microarray Gene Expression Measurements
Dai, Y. D., Almasri, E., Larsen, P. E., & Chen, G. (2010) · IGI Global eBooks · doi:10.4018/978-1-60566-685-3.ch012
“High-throughput data, such as protein-protein binding interactions and transcription factor ( Whitfield, George, Grant & Perou, 2006 ) binding locations in DNA sequence, inevitably include both false positives and false negatives.”
Background
Nanowire Transistor–Based DNA Methylation Detection
Maki, W. C., Maki, G. K., & Mishra, N. (2012) · Series in sensors · doi:10.1201/b12138-51
Genetics of Adrenocortical Cancers
Assié, G., & Bertherat, J. Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_4
Estudo do efeito da remediação simultânea dos genes p16INK4a e p53 mediada pelo adenovírus bicistrônico Adp16IRESp53 em um modelo de carcinoma de pulmão humano.
Gregorio, J. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2019.tde-22022010-115327
Evaluating downstream targets of cullin4-dependent E3 ligases and of D-type cyclins: implications for the dysregulation of ubiquitination and cell growth in cancer
Zacharek, S. J. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tp9d-5n23
Identification of different cell clusters in the endothelium of atherosclerotic vessels and determination of inter-cluster gradient of proliferative and inflammatory activity as new diagnostic markers
Nikitin, P. V., Ryzhova, M., Galstyan, S., Kim, D., Зубова, И. В., Khokhlova, E., & Shugay, S. V. (2020) · Biotechnic & Histochemistry · doi:10.1080/10520295.2020.1823016
“Ki-67 is a marker for proliferative activity in cells and tissues (Whitfield et al. 2006; Yerushalmi et al. 2010).”
MODELING VERTEBRATE ADULT STEM CELLS AND THEIR PROGENY
Post, Y. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/143
Immune cell networks uncover candidate biomarkers of cancer immunotherapy responsePreprint
Vo, D. H., McGleave, G., & Overton, I. (2021) · bioRxiv · doi:10.1101/2021.04.22.440902
“Activation of proliferation in tumour epithelium is typically a poor prognosis factor [84] and so inclusion of cell”
Background
Studies on Stem Cell Biology Using a Fluorescent Ubiquitination-based Cell Cycle Indicator
Yo, M., & 楊, 正. (2015)
Using semantics to scale up evidence-based chemical risk-assessments
Blake, C. L., & Flaws, J. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260712
“Although genes are common markers of cell proliferation [40], the National Cancer Institute’s definition of cell proliferation is used in this paper, which is “An increase in the number of cells as a result of cell growth and cell division” (see Fig 2).”
Background
Uncovering Tumorigenesis Circuitry with Combinatorial CRISPR
Fong, S. H., Munson, B. P., & Ideker, T. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-3672
“As cell proliferation is well known to be closely associated with sweeping changes in transcription (10), it is perhaps not surprising that epistasis at the fitness level corresponds to epistasis in gene expression.”
Background
STANDARDIZATION OF KI-67 AS A BIOMARKER OF CELL PROLIFERATION
Zhylkibayev, A. A., Sarina, N. I., Mun, E. A., & Eskendirova, S. Z. (2019) · Eurasian journal of applied biotechnology · doi:10.11134/btp.2.2019.1
“Many factors affecting the course and outcome of oncological diseases are mediated through a change in proliferative activity [1,2].”
Background
Identification of the Gene for Scleroderma in the Tsk/2 Mouse Strain: Implications for Human Scleroderma Pathogenesis and subset Distinctions
Blankenhorn, E. P., Whitfield, M. L., & Artlett, C. M. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada613588
Self-citation
Faculty Opinions recommendation of Most random gene expression signatures are significantly associated with breast cancer outcome.
Coles, M. C., & Brown, L. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13360978.793557096
Mechanosensitive Changes in the Expression of Cancer-Associated Genes in Colorectal Cancer-Associated FibroblastsPreprint
Emon, B., song, Y. J., Kovour, M. V., Prasanth, K. V., & Saif, T. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4075598
CLINICOPATHOLOGICAL STUDY OF ORAL SQUAMOUS CELL CARCINOMAS WITH SPECIAL EMPHASIS ON E6, E7 ONCOPROTEIN EXPRESSION AND KI67 LABELLING INDEX
Chowdhury, A., Kangsabanik, B., & Mondal, P. (2022) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/2700959
TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progressionPreprint
Wang, H., Cui, H., Yang, X., & Peng, L. (2022) · Research Square · doi:10.21203/rs.3.rs-2250953/v1
Identification of potential crucial genes associated with breast cancer using bioinformatics analysis and experimental verificationPreprint
Ni, X., Yang, H., & Liu, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2457642/v1
Data from Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
Wilkerson, M. D., Yin, X., Hoadley, K. A., Liu, Y., Hayward, M. C., Cabanski, C. R., Muldrew, K. L., Miller, C. R., Randell, S. H., Socinski, M. A., et al. (2023) · doi:10.1158/1078-0432.c.6519170.v1
Self-citation
Data from Immutable Functional Attributes of Histologic Grade Revealed by Context-Independent Gene Expression in Primary Breast Cancer Cells
Dairkee, S. H., Sayeed, A., Luciani, G., Champion, S., Meng, Z., Jakkula, L. R., Feiler, H. S., Gray, J. W., & Moore, D. H. (2023) · doi:10.1158/0008-5472.c.6500349
Supplementary Table 4 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
Salvatore, G., Nappi, T. C., Salerno, P., Jiang, Y. Y., Garbi, C., Ugolini, C., Miccoli, P., Basolo, F., Castellone, M. D., Cirafici, A. M., et al. (2023) · doi:10.1158/0008-5472.22371702
Supplementary Figures 1-2, Tables 1-2 from Serial Transcriptome Analysis and Cross-Species Integration Identifies Centromere-Associated Protein E as a Novel Neuroblastoma Target
Balamuth, N., Wood, A. M., Wang, Q., Jagannathan, J., Mayes, P. A., Zhang, Z., Chen, Z., Rappaport, E. F., Courtright, J., Pawel, B., et al. (2023) · doi:10.1158/0008-5472.22385684
Supplementary Data from Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Etemadmoghadam, D., DeFazio, A., Beroukhim, R., Mermel, C. H., George, J., Getz, G. A., Tothill, R. W., Okamoto, A., Raeder, M. B., Harnett, P. R., et al. (2023) · doi:10.1158/1078-0432.22440150.v1
Data from Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Etemadmoghadam, D., DeFazio, A., Beroukhim, R., Mermel, C. H., George, J., Getz, G. A., Tothill, R. W., Okamoto, A., Raeder, M. B., Harnett, P. R., et al. (2023) · doi:10.1158/1078-0432.c.6517518
Data from Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer
Ghazoui, Z. F., Buffa, F. M., Dunbier, A. K., Anderson, H., Dexter, T., DETRE, S. I., Salter, J., Smith, I. E., Harris, A. L., & Dowsett, M. (2023) · doi:10.1158/1078-0432.c.6518916
Data from Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
Wilkerson, M. D., Yin, X., Hoadley, K. A., Liu, Y., Hayward, M. C., Cabanski, C. R., Muldrew, K. L., Miller, C. R., Randell, S. H., Socinski, M. A., et al. (2023) · doi:10.1158/1078-0432.c.6519170
Self-citation
Data from Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression
Castellano, G., Malaponte, G., Mazzarino, M. C., Figini, M., Marchese, F., Gangemi, P., Travali, S., Stivala, F., Canevari, S., & Libra, M. (2023) · doi:10.1158/1078-0432.c.6517251.v1
Data from Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women
Servant, N., Bollet, M. A., Halfwerk, H., Kevin Bleakley, A., Kreike, B., Jacob, L., Sie, D., Kerkhoven, R. M., Hupé, P., Hadhri, R., et al. (2023) · doi:10.1158/1078-0432.c.6520737.v1
Supplementary Figures 1-2, Tables 1-2 from Serial Transcriptome Analysis and Cross-Species Integration Identifies Centromere-Associated Protein E as a Novel Neuroblastoma Target
Balamuth, N., Wood, A. M., Wang, Q., Jagannathan, J., Mayes, P. A., Zhang, Z., Chen, Z., Rappaport, E. F., Courtright, J., Pawel, B., et al. (2023) · doi:10.1158/0008-5472.22385684.v1
Data from Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women
Servant, N., Bollet, M. A., Halfwerk, H., Kevin Bleakley, A., Kreike, B., Jacob, L., Sie, D., Kerkhoven, R. M., Hupé, P., Hadhri, R., et al. (2023) · doi:10.1158/1078-0432.c.6520737
Supplementary Data from Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Etemadmoghadam, D., DeFazio, A., Beroukhim, R., Mermel, C. H., George, J., Getz, G. A., Tothill, R. W., Okamoto, A., Raeder, M. B., Harnett, P. R., et al. (2023) · doi:10.1158/1078-0432.22440150
Supplementary Data from Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer
Ghazoui, Z. F., Buffa, F. M., Dunbier, A. K., Anderson, H., Dexter, T., DETRE, S. I., Salter, J., Smith, I. E., Harris, A. L., & Dowsett, M. (2023) · doi:10.1158/1078-0432.22442094
Supplementary Table 4 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
Salvatore, G., Nappi, T. C., Salerno, P., Jiang, Y. Y., Garbi, C., Ugolini, C., Miccoli, P., Basolo, F., Castellone, M. D., Cirafici, A. M., et al. (2023) · doi:10.1158/0008-5472.22371702.v1
Data from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Li, X., Dowling, E. K., Yan, G., Dereli, Z., Bozorgui, B., Imanirad, P., Elnaggar, J. H., Luna, A., Menter, D. G., Pilie, P. G., et al. (2023) · doi:10.1158/2159-8290.c.6549560.v1
Supplementary Table from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Li, X., Dowling, E. K., Yan, G., Dereli, Z., Bozorgui, B., Imanirad, P., Elnaggar, J. H., Luna, A., Menter, D. G., Pilie, P. G., et al. (2023) · doi:10.1158/2159-8290.22541159.v1
Supplementary Figure from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Li, X., Dowling, E. K., Yan, G., Dereli, Z., Bozorgui, B., Imanirad, P., Elnaggar, J. H., Luna, A., Menter, D. G., Pilie, P. G., et al. (2023) · doi:10.1158/2159-8290.22541171.v1
Supplementary Figure from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Li, X., Dowling, E. K., Yan, G., Dereli, Z., Bozorgui, B., Imanirad, P., Elnaggar, J. H., Luna, A., Menter, D. G., Pilie, P. G., et al. (2023) · doi:10.1158/2159-8290.22541171
Multicenter integrative analysis identifies a multigene signature for lung adenocarcinoma prognosis via glycolysis metabolism discoordinationPreprint
Zhang, N., Dong, W., Li, J., Luo, Y., Zhu, K., Ren, J., Li, L., Zhang, X., & Liu, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2945435/v1
The roles of DDR2 and substrate stiffness on cancer cell transcriptome and proliferationPreprint
Vessella, T., Xiang, S., Cong, X., Stilwell, M., Shohet, J. M., Rozen, E. J., Zhou, H. S., & Wen, Q. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.29.564363
Enhanced NK cell proliferation by stress-induced feeder cellsPreprint
Lee, D., Song, M., & Kwon, S. (2024) · Research Square · doi:10.21203/rs.3.rs-3918793/v1
Developing DNA Aptamer Toolbox for Cell Research
Yue, L., Wang, S., & Tan, W. (2024) · doi:10.1002/9783527840816.ch1
Repression of the Wnt pathway effector TCF7L2 reverses lethal cachexia in mice with intestinal cancersPreprint
Leong, M. L., Ruedl, C., & Karjalainen, K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.22.624913
Partial Proliferating Cell Nuclear Antigen Functional Knockout Impairs Cisplatin Resistance and Clonogenic Potential in Lung Adenocarcinoma Cells
Morelli, A. P., Ruiz, N. Q., Mancini, M. C. S., Pavan, I. C. B., Flores, I. L., da Silva, L. G. S., Severino, M. B., Bezerra, R. M. N., & Simabuco, F. M. (2025) · DNA · doi:10.3390/dna5010007
“PCNA is also used as a marker of cell proliferation [9] and is commonly overexpressed in cancer cells.”
Investigating the Pathology-Related Astroglial Plasticity in the Human Cerebral Cortex
Sirko, S., & Vecchia, P. D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4366-2_11
Stabilization of GTSE1 by cyclin D1-CDK4/6-mediated phosphorylation promotes cell proliferation: relevance in cancer prognosisPreprint
García-Vázquez, N., González-Robles, T. J., Lane, E., Spasskaya, D. S., Zhang, Q., Kerzhnerman, M. A., Jeong, Y., Collu, M., Simoneschi, D., Ruggles, K. V., et al. (2025) · eLife · doi:10.7554/elife.101075.2
Whole-Proteome Screening and Multi-Modal Profiling of Antigen-Specific CD4+ T Cells at Single-Cell ResolutionPreprint
Zhang, R., Jin, Q., McKasson, M., Choi, J., Gutiérrez, V., Brennan, C., Hong, S., Chour, W., Ng, R. H., Xie, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.21.649828
“Additionally, a small cluster of cells displays high expression of proliferation markers, including MKI67, MYBL2, BUB1, PLK1, and CCNE1 51 .”
Repression of the Wnt pathway effector TCF7L2 reverses lethal cachexia in mice with intestinal cancersPreprint
Leong, M. L., Ruedl, C., & Karjalainen, K. (2025) · eLife · doi:10.7554/elife.104926.1
Repression of the Wnt pathway effector TCF7L2 reverses lethal cachexia in mice with intestinal cancersPreprint
Leong, M. L., Ruedl, C., & Karjalainen, K. (2025) · eLife · doi:10.7554/elife.104926
Mesenchymal-epithelial transition serves to rapidly, yet transiently, restore the endometrial epithelium during postpartum murine uterine regenerationPreprint
Wang, Z., Davenport, K. M., Behura, S. K., & Patterson, A. L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.05.652287
The Global Burden of Chronic Lymphocytic Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2021 Study and Projections to 2035Preprint
Zhu, L., Fan, L., Peng, S., Luo, X., & Wen, J. (2025) · Research Square · doi:10.21203/rs.3.rs-6751105/v1 · Cited by 1
Interventionally-guided representation learning for robust and interpretable AI models in cancer medicinePreprint
Kirkham, D., Masina, R., Sammut, S.-J., Mukherjee, S., & Rueda, O. (2025) · bioRxiv · doi:10.1101/2025.07.21.662350 · Cited by 1

Authors: Whitfield, M. L., George, L. K., Grant, G. D., & Perou, C. M.
Affiliations: Dartmouth College (US)
University of North Carolina at Chapel Hill (US)
Corresponding author: Whitfield, Michael L.
ORCID: Whitfield, Michael L.
Grant, Gavin D.
Perou, Charles M.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2006-02
Volume: 6
Issue: 2
Pages: 99-106
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1802
OpenAlex: W2018173663
Cited by: 650
References: 66
Citations by year: 2026: 31 · 2025: 46 · 2024: 35 · 2023: 54 · 2022: 53 · 2021: 54 · 2020: 33 · 2019: 29 · 2018: 22 · 2017: 27 · 2016: 34 · 2015: 15 · 2014: 17 · 2013: 27 · 2012: 26
FWCI: 2.57
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: cell proliferation, proliferation signature, gene expression profiling, tumor markers, cell cycle, carcinogenesis, cancer diagnosis, cancer prognosis
MeSH terms: Cell Cycle, Genetic Markers, Humans, Neoplasms, Prognosis, RNA, Messenger, Biomarkers, Tumor, Gene Expression Profiling, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Common markers of proliferation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks